Cara Therapeutics Adds 9% In Morning Trade

Shares of Cara Therapeutics, Inc. (CARA) are rising more than 9% Tuesday morning after analysts at JPMorgan upgraded the company to "Overweight".

The brokerage set a new price target of $20, up from the previous goal of $17, for the company on Tuesday.

Cara stock, currently at $11.51, has traded in the range of $9.63-$29.65 in the past 52 weeks.

For comments and feedback contact: editorial@rttnews.com

Business News

Looking to Invest in the Best Biotech Stocks? Subscribe to RTT Biotech Investor.
Follow RTT